Results 131 to 140 of about 13,146 (180)

Treating depression in dialysis patients: pharmacological and non-pharmacological approaches. [PDF]

Clin Kidney J
Cukor D, Cornelius C, Dahl K, Figueiredo D, Sousa H, Archey A, Kimmel PL.   +6 more
europepmc   +1 more source

Mirtazapine is a functional antagonist at cardiac human H₁-histamine receptors. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Pham TH, Schlicht JMA, Hofmann B, Kirchhefer U, Neumann J, Gergs U.   +5 more
europepmc   +1 more source

Error in Visual Abstract.

JAMA Psychiatry
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mirtazapine, an antidepressant.

American Journal of Health-System Pharmacy, 1998
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of mirtazapine are reviewed. Mirtazapine is a new anti-depressant that blocks presynaptic alpha 2-adrenergic receptors and postsynaptic serotonin type 2 and type 3 receptors. Mirtazapine has FDA-approved labeling for treatment of depression.
Talia Puzantian
exaly   +3 more sources